In
this issue:
- Colony
management solutions
- New
JAX® Mice Price List
- The JAX® Mice
difference
- Join
us at the American Diabetes Association Meeting
- JAX® Mice
strains under development
- Recent
publications co-authored by Jackson Laboratory
professors
Colony
management solutions
Make
better use of limited resources and and simplify all
aspects of managing your mouse colonies—all
with our breeding and cryopreservation services.
You can depend on our expertise maintaining laboratory
mice. Our experience maintaining the world's largest
mouse model collection enables us to develop cost-effective,
time-efficient breeding solutions to fit your needs.
In addition, we have successfully cryopreserved
and recovered more than 5,000 mouse strains. Contact
us today to simplify and accelerate your research.
New
JAX® Mice Price List
Our
new 2008-2009 JAX® Mice Price List
includes over 500 new strains. To
request a copy of the new Price List (available June
1), please visit our Web site. For a list
of new strains by research area, visit our newly
released strains webpage.
The
JAX® Mice Difference
Not
only are JAX Mice the most published and well
characterized, they are healthiest, most genetically
stable models available, and they are supported
by our exper technical scientists. Learn how
we ensure the integrity of JAX® Mice
for your research with our animal
health and genetic
testing and monitoring programs or contact our technical
support team today.
Join
us at the American Diabetes Association Meeting
Stop
by booth 226 at ADA in San Francisco,
CA, from June 6-9, 2008 to meet our research scientists,
product managers, and technical support, customer service
and regional representatives. View a list of future
meetings we will be attending.
New
JAX® Mice strains under development
You can find more information about these and other JAX® Mice strains by searching the JAX® Mice Database. To submit your unique research strain(s) to our international repository for mouse models, see our Strain Submission Form.
- 129S1-Sv-Sufutm1Aeb/J
(007859)
Mice homozygous for the suppressor of fused homolog (Drosophila)
(Sufu) gene are viable and fertile. This mutant mouse strain
represents a model that may be used to study neuronal
differentiation.

- B10.Cg-Thy1a
H2d Tg(TcraCl1,TcrbCl1)1Shrm/J
(005895) These
Clone-1 TCR (also called Clone 1 Thy1.1
TCR or Cl.1 TCR) transgenic mice were
designed to optimize conditions for
tumor eradication by low avidity tumor-specific
T cells and may also be used to study
T cell avidity,
tolerance, positive/negative
selection,
and activation.

- B6.129-Fut1tm1Sdo/J
(006939) Fucosyltransferase
1 (Fut1) -deficient mice do not have epididymal
alpha(1,2)fucosylated glycans or the fucosylated glycolipid,
fucosyl GA1, in pancreatic acinar glands. Homozygotes
exhibit delayed maturation of nerve fibers in the glomerular
layer of the olfactory bulb. This mutant mouse strain
may be used to study glycosidic molecular interactions
and function, and olfactory nerve pathway development.

- B6.129-Mgl1tm1Hed/J
(006944) Macrophage
galactose N-acetyl-galactosamine specific
lectin 1 (Mgl1) -deficient
mice exhibit slightly increased red
blood cell counts, mean corpuscular
hemoglobin, hematocrit and mean corpuscular
volume when compared to wildtype controls.
Homozygotes have diminished antigen-induced
granulation tissue formation. This
mutant mouse strain may be used to
study glycosidic molecular
interactions and function, antigen-specific and
antigen-independent cellular
immune response and hematopoiesis.

- B6.Cg-Tg(THY1-SNCA*A53T)M53Sud/J
(008135) Hemizygous transgenic mice are viable and fertile and develop a Parkinson-like phenotype upon aging. Hind limb paralysis due to loss of motor neurons and a resting tremor are initially seen at about 6 months of age. No Lewy body-like pathology is noted. Cell death in the spinal cord (extensive) and brain are observed.

- B6;129P2-Pvalbtm1(cre)Arbr/J
(008069) This
strain expresses Cre recombinase from the endogenous Pvalb,
parvalbumin, locus. When crossed with a strain
containing a floxed target sequence
of interest, Cre-mediated recombination results
in deletion of the target in interneurons in the
brain and sensory neurons in the dorsal root ganglia.
- B6;SJL-Tg(Tagln-tTA)1Mrab
Tg(tetO-Mcpt1)1Mrab/J (008082) These
SM22a-tTA/TRE-RVCH-HA bi-transgenic mice allow
targeted overexpression or Tet-Off conditional
expression of vascular chymase in smooth muscle
cells, and may be used to study elevated chymase
activity in systemic hypertension and cardiovascular disease.

- BXD70/RwwJ
(007115) The BXD#/Rww recombinant inbred (RI) strains originate from crosses between C57BL/6J (000664) females and DBA/2J (000671) males and were generated using a strategy of advanced intercrosses (AI). They may be used to study the genetics of behavioral phenotypes (including alcohol and drug
, stress, and locomotor activity) and complex or potentially complex physiologic phenotypes (including differences in organ
weight and bone mineral density).

- (C57BL/6-Tg(TRAMP)8247Ng/J X FVB/NJ)F1/J (008215) These
transgenic mice express the simian virus 40 (SV40)
large tumor T antigen (Tag) under the control of
the rat probasin promoter. Mice
carrying the TRAMP (Transgenic Adenocarcinoma of
Mouse Prostate) transgene develop progressive forms
of prostate cancer with distant
site metastasis, primarily to the lymph nodes and
lungs.

- NOD.Cg-Tg(Ins1-EGFP)1Hara/QtngJ
(008173) Congenic
NOD mice hemizygous for enhanced green florescent
protein, EGFP, under the control of the Mouse
Insulin I promoter, InsI, (MIP-GFP)
express green florescence in tissues where
insulin I is normally detected, specifically
in pancreatic beta-cells. Transgenic female
mice develop insulitis and diabetes at a
similar or higher rate as wildtype
controls. Transgenic mice may be used to study diabetes and pancreatic
beta islet cell biology.

- NOD.FVB-Tg(Igh-6-Cd80)1Gjf/JbsJ
(007769) This
congenic NOD strain contains a transgene encoding
murine Cd80 controlled by IgM enhancer and
promoter elements and is commonly referred
to as NOD.B7-1B Tg. The donating investigator
reports that this diabetes resistant strain
expresses high levels of the transgene on B
cells, but not on T-cells. Circulating, splenic,
and bone marrow B cells are significantly reduced.
This strain may be used to study autoreactive T
cell activation, B cell depletion and
the role of B7 costimulatory molecules in autoimmunity,
specifically Type
1 Diabetes.

- STOCK Gt(ROSA)26Sortm1(Notch1)Dam/J
(008159) Expression
of the Notch1 intracellular domain fragment
and GFP is blocked by a loxP-flanked STOP fragment
placed between the coding sequence the the
GT(ROSA)26Sor promoter. When used in conjunction
with a Cre recombinase-expressing strain, these
RosaN1-IC
mutant mice may be useful in generating conditional
mutations for studying the effects of Notch
pathway activation.

- STOCK
Tg(Ins2-cre/Esr1)1Dam/J (008122) When
these RIP-CreER mice are bred with mice containing
a loxP-flanked sequence of interest, tamoxifen-inducible,
Cre-mediated recombination will result in deletion
of the flanked sequences in pancreatic beta cells.
This mutant mouse strain may be used to study pancreatic
development, diabetes and obesity.

- STOCK Tg(Ins2-rtTA)2Efr/J
(008250) Ins-rtTA or RIP7-rtTA transgenic mice express the reverse tetracycline-controlled transactivator (rtTA) protein under the control of the rat insulin 2 promoter. When mated to a second transgenic strain carrying a gene under the regulatory control of a tetracycline-responsive promoter element (TRE or tetO), expression of the gene in pancreatic beta cells is induced with administration of the tetracycline analog, doxycycline (dox). This strain provides a Tet-On tool that allows the inducible expression of genes in pancreatic
beta cells.

- STOCK
Tg(Neurog3-cre/Esr1)1Dam/J (008119) When
these Ngn3/CreER mice are bred with mice containing
a loxP-flanked sequence of interest, tamoxifen-inducible,
Cre-mediated recombination will result in deletion
of the flanked sequences in Neurog3 expressing
cells such as pancreatic islet cells and undifferentiated
spermatogonia. This mutant mouse strain may be
used to study pancreatic development and lineage mapping of Neurog3 expressing cells.

- STOCK
Tg(tetO-DTA)1Gfi/J (008168) These
tet-diphtheria toxin A mice may be used to generate
bi-transgenic mice mutants for reversible, inducible
deletion of specific groups of cells.

Recent
publications co-authored by
Jackson Laboratory professors
Lozier J, McCright B, Gridley
T. Notch signaling regulates bile duct morphogenesis in mice. PLoS
ONE 2008 Mar; 3(3):e1851. PubMed:[18365007]
Mackiewicz M, Paigen
B, Naidoo N, Pack AI. Analysis of the QTL for sleep homeostasis in mice: Homer1a is a likely candidate. Physiol
Genomics 2008; 33:91-99. PubMed:[18171722]
Perera SA, Maser RS, Xia H, McNamara K, Protopopov A, Chen L, Hezel AF, Kim CF, Bronson
RT, Castrillon DH, Chin L, Bardeesy N, DePinho RA, Wong K-K. Telomere dysfunction promotes genome instability and
metastatic potential in a K-ras p53 mouse model of lung cancer.
Carcinogenesis
2008; 29(4):747-53. PubMed:[18283039]
Renaud J, Kerjan G, Sumita I, Zagar Y, Georget V, Kim
D, Fouquet C, Suda K, Sanbo M, Suto F, Ackerman
SL, Mitchell KJ, Fujisawa H, Chédotal A. Plexin-A2 and its ligand, Sema6A, control nucleus- centrosome coupling in migrating granule cells. Nat
Neurosci 2008 Apr; 11(4):440-9. PubMed:[18327254]
Stylianou IM, Affourtit JP, Shockley KR, Wilpan
RY, Abdi FA, Bhardwaj S, Rollins J, Churchill
GA, Paigen B. Applying gene expression, proteomics and single-nucleotide polymorphism analysis for complex trait gene identification. Genetics
2008 Mar; 178(3):
1795-805. PubMed:[18245842]
Wong SY, Crowley D, Bronson
RT, Hynes RO. Analyses of the role of endogenous SPARC in mouse models of prostate and breast cancer. Clin
Exp Metastasis 2008; 25:109-118. PubMed:[18058030]
Thank you for your interest in JAX® Mice and Services.
Jennifer Guilmet
Regional Representative
The Jackson Laboratory
Email: jennifer.guilmet@jax.org
Tel: 617-780-2566